| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
5.7 0.1 (0.02%) |
09-21 09:30 |
|
Open: |
5.73 |
Pre close: |
5.6 |
Target:
|
7.51
|
|
High: |
5.7 |
Low: |
5.7 |
Resistance:
|
6.43
6.98
|
|
Volume: |
124 |
Market Cap: |
35M |
Support:
|
5.54
4.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.80
 |
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
6.25 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
5.30  |
Stochastic Oscillator |
%K(14,3):
|
8.08 |
|
MA(250): |
5.38 |
%D(3): |
8.55 |
|
Average Volume(K) |
3-Month: |
242909
|
52-Week |
High:
|
7.95 |
|
10-Days: |
2780 |
Low: |
3.50 |
|
RSI |
RSI(14):
|
41.27 |
Change(%): |
21.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.510 |
Return on Equity (ttm) |
-92.5 |
Shares Out. (M) |
6.21 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-28.8 |
Shares Float (M) |
5.33 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.73 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
5.6 |
% Held by Institutions |
37.10 |
|
Forward EPS |
-0.510 |
Gross Profit (p.s.) |
-0.245 |
Shares Short (K) |
294 |
|
Book Value (p.s.) |
1.910 |
EBITDA (p.s.) |
-2.683 |
P/E |
-1.26 |
|
Sales Per Share |
1.267 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.98 |
|
Profit Margin |
-218.12 |
Operating Cash Flow
(M) |
-16.81 |
P/S |
4.50 |
|
Operating Margin |
-224.66 |
Levered Free Cash Flow
(M) |
-10.52 |
P/CF |
-2.11 |
|
|
|
|
|
|
